Literature DB >> 19795521

Anti-Ro52/SSA antibody-exposed fetuses with prolonged atrioventricular time intervals show signs of decreased cardiac performance.

G Bergman1, H Eliasson, K Bremme, M Wahren-Herlenius, S-E Sonesson.   

Abstract

OBJECTIVE: To investigate if anti-Ro/SSA antibody-exposed fetuses with prolonged atrioventricular (AV) time intervals also have prolongation of the isovolumetric contraction time (ICT).
METHODS: Seventy-eight anti-Ro/SSA (including 70 anti-Ro52) antibody-exposed fetuses at risk for congenital heart block (CHB) were followed weekly, between 18 and 24 weeks of gestation, with two Doppler echocardiographic methods designed to detect signs of first-degree AV block. One of these AV time measurements, using hemodynamic events from the mitral valve and aortic outflow as indirect markers of atrial and ventricular depolarization (MV-Ao), was also used to calculate a time interval representing an early phase of systolic cardiac performance, i.e. the ICT. Two hundred and eighty-four women with normal pregnancies served as controls for AV time intervals and another 106 were used to establish an ICT reference range.
RESULTS: Strong positive relationships were found between ICT and MV-Ao time intervals (r = 0.91, P < 0.001), as well as between ICT and time intervals obtained from the superior vena cava and aorta (r = 0.85, P < 0.001). The ICT was estimated to contribute more than 50% of the total AV time prolongation. Abnormal AV time and ICT intervals were only seen in anti-Ro52 positive pregnancies.
CONCLUSIONS: The ICT is an important contributor to prolongation of AV time intervals. This observation suggests that anti-Ro52/SSA antibody-exposed fetal hearts have not only disturbed electrical conduction but also decreased mechanical performance. Moreover, our findings have implications for the interpretation of AV time intervals used for surveillance of fetuses at risk for developing CHB. Copyright (c) 2009 ISUOG. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19795521     DOI: 10.1002/uog.7343

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  6 in total

1.  Assessment of atrioventricular conduction by echocardiography and magnetocardiography in normal and anti-Ro/SSA-antibody-positive pregnancies.

Authors:  B F Cuneo; S Bitant; J F Strasburger; A M Kaizer; R T Wakai
Journal:  Ultrasound Obstet Gynecol       Date:  2019-11       Impact factor: 7.299

2.  Identification of discrete epitopes of Ro52p200 and association with fetal cardiac conduction system manifestations in a rodent model.

Authors:  A Hoxha; A Ruffatti; A Ambrosi; V Ottosson; M Hedlund; L Ottosson; M Anandapadamanaban; M Sunnerhagen; S-E Sonesson; M Wahren-Herlenius
Journal:  Clin Exp Immunol       Date:  2016-09-13       Impact factor: 4.330

3.  Brazilian Fetal Cardiology Guidelines - 2019.

Authors:  Simone R F Fontes Pedra; Paulo Zielinsky; Cristiane Nogueira Binotto; Cristiane Nunes Martins; Eduardo Sérgio Valério Borges da Fonseca; Isabel Cristina Britto Guimarães; Izabele Vian da Silveira Corrêa; Karla Luiza Matos Pedrosa; Lilian Maria Lopes; Luiz Henrique Soares Nicoloso; Marcia Ferreira Alves Barberato; Marina Maccagnano Zamith
Journal:  Arq Bras Cardiol       Date:  2019-06-06       Impact factor: 2.000

Review 4.  Electromechanical reciprocity and arrhythmogenesis in long-QT syndrome and beyond.

Authors:  Katja E Odening; Henk J van der Linde; Michael J Ackerman; Paul G A Volders; Rachel M A Ter Bekke
Journal:  Eur Heart J       Date:  2022-08-21       Impact factor: 35.855

5.  Auxilin is a novel susceptibility gene for congenital heart block which directly impacts fetal heart function.

Authors:  Sabrina Meisgen; Malin Hedlund; Aurelie Ambrosi; Lasse Folkersen; Vijole Ottosson; David Forsberg; Gudny Ella Thorlacius; Luca Biavati; Linn Strandberg; Johannes Mofors; Daniel Ramskold; Sabrina Ruhrmann; Lauro Meneghel; William Nyberg; Alexander Espinosa; Robert Murray Hamilton; Anders Franco-Cereceda; Anders Hamsten; Tomas Olsson; Lois Greene; Per Eriksson; Kristina Gemzell-Danielsson; Stina Salomonsson; Vijay K Kuchroo; Eric Herlenius; Ingrid Kockum; Sven-Erik Sonesson; Marie Wahren-Herlenius
Journal:  Ann Rheum Dis       Date:  2022-04-25       Impact factor: 27.973

6.  Serological epitope profile of anti-Ro52-positive patients with systemic autoimmune rheumatic diseases.

Authors:  Maria Infantino; Francesca Meacci; Valentina Grossi; Maurizio Benucci; Gabriella Morozzi; Elio Tonutti; Marilina Tampoia; Antonina Ott; Wolfgang Meyer; Fabiola Atzeni; Piercarlo Sarzi-Puttini; Mariangela Manfredi; Nicola Bizzaro
Journal:  Arthritis Res Ther       Date:  2015-12-17       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.